These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 35811086

  • 1. Management of Cepacia syndrome in an immunocompetent non-cystic fibrosis adult patient.
    Ottu Para NK, Vemuri S, Koshy G, Ibrahim D, Oomen S, Reddappa SV, Nadaf MS, Irfan RM, Wyon N, Ahmed MZ, Sundaram S.
    Int J Infect Dis; 2022 Sep; 122():550-552. PubMed ID: 35811086
    [Abstract] [Full Text] [Related]

  • 2. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H, Lenney W, Gilchrist FJ.
    BMC Pharmacol Toxicol; 2016 Mar 28; 17():14. PubMed ID: 27018049
    [Abstract] [Full Text] [Related]

  • 3. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
    Horsley A, Webb K, Bright-Thomas R, Govan J, Jones A.
    Front Cell Infect Microbiol; 2011 Mar 28; 1():18. PubMed ID: 22919584
    [Abstract] [Full Text] [Related]

  • 4. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH, Bhatt J.
    Cochrane Database Syst Rev; 2019 Apr 18; 4(4):CD009876. PubMed ID: 30997925
    [Abstract] [Full Text] [Related]

  • 5. Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections.
    El-Halfawy OM, Naguib MM, Valvano MA.
    Antimicrob Resist Infect Control; 2017 Apr 18; 6():120. PubMed ID: 29204272
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A, Jones AM.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD009529. PubMed ID: 23076960
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
    Gilchrist FJ, Webb AK, Bright-Thomas RJ, Jones AM.
    J Cyst Fibros; 2012 Sep 17; 11(5):458-60. PubMed ID: 22551926
    [Abstract] [Full Text] [Related]

  • 8. Burkholderia cepacia infection associated with sickle cell disease: An uncommon entity.
    Singh P, Patro S, Deep A, Mohapatra SK.
    Trop Doct; 2023 Apr 17; 53(2):303-304. PubMed ID: 36916218
    [Abstract] [Full Text] [Related]

  • 9. When is Burkholderia cepacia complex truly eradicated in adults with cystic fibrosis? A 20-year follow up study.
    Tewkesbury DH, Pollard LR, Green HD, Horsley A, Kenna D, Jones AM.
    J Cyst Fibros; 2024 Jan 17; 23(1):87-90. PubMed ID: 37775444
    [Abstract] [Full Text] [Related]

  • 10. Is prolonged incubation required for optimal recovery of Burkholderia cepacia complex in sputum from cystic fibrosis patients? Data versus dogma.
    Naqvi S, Varadhan H, Givney R.
    Pathology; 2020 Apr 17; 52(3):366-369. PubMed ID: 32113671
    [Abstract] [Full Text] [Related]

  • 11. Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment.
    Daccò V, Alicandro G, Consales A, Rosazza C, Sciarrabba CS, Cariani L, Colombo C.
    Pediatr Pulmonol; 2023 May 17; 58(5):1337-1343. PubMed ID: 36815622
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A, Jones AM, Lord R.
    Cochrane Database Syst Rev; 2016 Jan 20; 2016(1):CD009529. PubMed ID: 26789750
    [Abstract] [Full Text] [Related]

  • 13. Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.
    Gruzelle V, Guet-Revillet H, Segonds C, Bui S, Macey J, Chiron R, Michelet M, Murris-Espin M, Mittaine M.
    BMC Pulm Med; 2020 Jun 05; 20(1):159. PubMed ID: 32503487
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
    Chang TH, Chuang YC, Wang JT, Sheng WH.
    J Microbiol Immunol Infect; 2022 Dec 05; 55(6 Pt 2):1301-1309. PubMed ID: 34674957
    [Abstract] [Full Text] [Related]

  • 15. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA, Carden JL, Goodwin DL, Smith TA, Gaggar A, Leon K, Antony VB, Rowe SM, Solomon GM.
    BMC Pulm Med; 2018 Feb 14; 18(1):35. PubMed ID: 29444656
    [Abstract] [Full Text] [Related]

  • 16. Burkholderia cepacia complex infection in a case of sinonasal polyposis recurrence without cystic fibrosis.
    Brescia G, Pavin A, Rinaldi R, Marioni G, Staffieri A.
    Auris Nasus Larynx; 2008 Sep 14; 35(3):414-6. PubMed ID: 17913420
    [Abstract] [Full Text] [Related]

  • 17. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.
    Zeiser ET, Becka SA, Wilson BM, Barnes MD, LiPuma JJ, Papp-Wallace KM.
    J Clin Microbiol; 2019 Aug 14; 57(8):. PubMed ID: 31167848
    [Abstract] [Full Text] [Related]

  • 18. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
    Lynch JP.
    Semin Respir Crit Care Med; 2009 Oct 14; 30(5):596-610. PubMed ID: 19760547
    [Abstract] [Full Text] [Related]

  • 19. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V, Singhal L, Ray P.
    Indian J Med Microbiol; 2011 Oct 14; 29(1):4-12. PubMed ID: 21304187
    [Abstract] [Full Text] [Related]

  • 20. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH, Bhatt J.
    Cochrane Database Syst Rev; 2016 Nov 02; 11():CD009876. PubMed ID: 27804115
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.